Beijing Beilu Pharmaceutical Co Ltd
300016
Company Profile
Business description
Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.
Contact
No. 3, Shuiyuan West Road
Miyun District
Beijing100082
CHNT: +86 1062625287
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,173
Stocks News & Analysis
stocks
3 overvalued ASX shares going into earnings
Prices of these shares exceed our Fair Value Estimate by more than double.
stocks
The long-term case for compounders
Compounders tend to deliver steadier, more durable profit growth across full cycles, making them better suited for long-term investors.
stocks
Record production for Woodside
Our fair value is updated as progress is made on new development projects.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,073.80 | 37.20 | -0.41% |
| CAC 40 | 8,126.53 | 55.17 | 0.68% |
| DAX 40 | 24,538.81 | 229.35 | 0.94% |
| Dow JONES (US) | 48,892.47 | 179.09 | -0.36% |
| FTSE 100 | 10,223.54 | 51.78 | 0.51% |
| HKSE | 26,906.71 | 480.40 | -1.75% |
| NASDAQ | 23,461.82 | 223.30 | -0.94% |
| Nikkei 225 | 53,482.90 | 160.05 | 0.30% |
| NZX 50 Index | 13,434.65 | 11.47 | 0.09% |
| S&P 500 | 6,939.03 | 29.98 | -0.43% |
| S&P/ASX 200 | 8,782.50 | 38.60 | -0.44% |
| SSE Composite Index | 4,086.05 | 31.89 | -0.77% |